![](/img/cover-not-exists.png)
A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery
D.C.H Cheng, C.D Mazer, R Martineau, A Ralph-Edwards, J Karski, J Robblee, B Finegan, R.I Hall, R Latimer, A VuylstekeVolume:
127
Year:
2004
Language:
english
Pages:
8
DOI:
10.1016/j.jtcvs.2003.08.024
File:
PDF, 112 KB
english, 2004